Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 15, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, is pleased to announce the appointment of Dr. Raymond Zheng as Chief Business Officer (CBO)....
International Cancer Organizations Present Collaborative Work During Oncology Event in China
The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO). XI'AN, China, Nov. 15, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is taking...
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 15, 2024 /PRNewswire/ -- SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for clinical-grade drug substance manufacturing. Following appropriate...
Mabwell’s Novel Nectin-4 Targeting ADC 9MW2821 Approved for 2 Clinical Trials by CDE of NMPA
SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has received IND approval for two clinical studies. The first will explore its use in combination with a PD-1 monoclonal antibody in the treatment of perioperative urothelial carcinoma, while the second will investigate its...
Baijiayun Was Awarded the “2024 Future Medical Technology Leader” and Gained Another Industry Recognition
BEIJING, Nov. 14, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced it was awarded the "2024 Future Medical Technology Leader". The 2024 Future Medical Technology Conference was grandly held in Beijing. As a leading audio and video technology enterprise in the domestic AI medical field for many...
I-Mab Reports Third Quarter 2024 Results
Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab in first-line mNSCLC in 1H 2025 Appointed Dr. Sean Fu as permanent CEO effective November 1, 2024 Estimated cash runway into 2027, based on $184.4 million...
Transforming Healthcare with Real-Time AI Image Analytic
Join us to discover how NVIDIA IGX and SDVoE enable seamless ultra-low latency solutions TAIPEI, Nov. 14, 2024 /PRNewswire/ -- Advantech announces enhanced AI detection for endoscopy surgical systems with the integration of its MIC-735M-IO, powered by NVIDIA IGX™, and the VEGA series ultra-low-latency SDVoE solution. Utilizing NVIDIA Holoscan AI software, this solution enables real-time AI surgical detection, transforming...
Cigna Healthcare Hong Kong announced as Title Sponsor for HYROX’s first Asian Championships
The Cigna Healthcare HYROX Open Asian Championships will bring over 6,300 fitness enthusiasts to Hong Kong HONG KONG, Nov. 14, 2024 /PRNewswire/ -- Cigna Healthcare Hong Kong, a leading health benefits provider, has announced its title sponsorship of the Cigna Healthcare HYROX Open Asian Championships 2024, solidifying its commitment to promoting...
Ubiquity Sprouting Corporation Unveils Prototype for Revolutionary Germinated Plant Milk Production System
TAIPEI, Nov. 14, 2024 /PRNewswire/ -- Ubiquity Sprouting Corporation has achieved a major milestone in the plant-based milk industry, completing the prototype of its innovative germinated plant milk production equipment. This cutting-edge technology, designed to work seamlessly with Ubiquity's specialized craft from germinating beans and seeds growing system to emulsifying technology, will soon enable consumers to enjoy a highly...
Lilly expands R&D footprint in Singapore with SGD$42 million investment in new Digital Health Innovation Hub
Lilly to drive next-generation AI-powered digital health technology research in Singapore SINGAPORE, Nov. 14, 2024 /PRNewswire/ -- Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), today announced the establishment of a SGD$42 million Digital Health Innovation Hub in Singapore to accelerate the research and development of AI-powered digital health technologies. This cutting-edge initiative forms the basis of a 5-year plan, supported by the Singapore Economic Development Board (EDB). A celebration event today marked the establishment of the Digital Health Innovation Hub held at the Lilly Centre for Clinical Pharmacology (LCCP),...
